FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022036486> ?p ?o ?g. }

• W2022036486 endingPage "703" @default.
• W2022036486 startingPage "695" @default.
• W2022036486 abstract "Effects were compared in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial of 2 mechanistically different strategies for treatment of hyperglycemia, insulin-sensitizing and insulin-providing strategies, on biomarker profiles reflecting the balance between fibrinolysis and thrombosis and the intensity of inflammation implicated in diabetic vasculopathy.A total of 2368 patients with type 2 diabetes mellitus and clinically stable, angiographically documented coronary artery disease were randomized to treatment with 1 of the 2 strategies and followed for an average of 5 years. Plasminogen activator inhibitor type 1 antigen and activity, tissue plasminogen activator antigen, fibrinogen, D-dimer, C-reactive protein, insulin, and hemoglobin A(1c) were assayed in blood samples acquired at baseline and at 12 regular intervals throughout the follow-up interval. Higher baseline D-dimer, fibrinogen, and C-reactive protein portended a poor prognosis in patients in both groups. In contrast to the insulin-providing strategy, the insulin-sensitizing strategy led to (1) lower plasma insulin; (2) lower plasminogen activator inhibitor type 1 antigen and activity and lower tissue plasminogen activator antigen (known to track with plasminogen activator inhibitor type 1); and (3) lower C-reactive protein and fibrinogen at all intervals after baseline (P<0.001 for each).The insulin-sensitizing treatment strategy led to changes in biomarker profiles indicative of decreased insulin resistance, an altered balance between thrombosis and fibrinolysis favoring fibrinolysis, and diminished intensity of the systemic inflammatory state, factors that have been associated with cardiovascular risk.http://www.clinicaltrials.gov. Unique identifier: NCT00006305." @default.
• W2022036486 created "2016-06-24" @default.
• W2022036486 creator A5000351033 @default.
• W2022036486 creator A5008504819 @default.
• W2022036486 creator A5035615314 @default.
• W2022036486 creator A5038199459 @default.
• W2022036486 creator A5059098934 @default.
• W2022036486 creator A5070819007 @default.
• W2022036486 creator A5071915821 @default.
• W2022036486 creator A5073676650 @default.
• W2022036486 creator A5077862111 @default.
• W2022036486 creator A5089724515 @default.
• W2022036486 creator A5089890051 @default.
• W2022036486 date "2011-08-09" @default.
• W2022036486 modified "2023-10-16" @default.
• W2022036486 title "Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial" @default.
• W2022036486 cites W1897800284 @default.
• W2022036486 cites W1994234329 @default.
• W2022036486 cites W2002833122 @default.
• W2022036486 cites W2004086352 @default.
• W2022036486 cites W2013077255 @default.
• W2022036486 cites W2032485049 @default.
• W2022036486 cites W2035614767 @default.
• W2022036486 cites W2040227938 @default.
• W2022036486 cites W2040745954 @default.
• W2022036486 cites W2053509650 @default.
• W2022036486 cites W2062992374 @default.
• W2022036486 cites W2075584741 @default.
• W2022036486 cites W2082432305 @default.
• W2022036486 cites W2086365883 @default.
• W2022036486 cites W2087044665 @default.
• W2022036486 cites W2091066652 @default.
• W2022036486 cites W2092881968 @default.
• W2022036486 cites W2093550819 @default.
• W2022036486 cites W2096773810 @default.
• W2022036486 cites W2099891998 @default.
• W2022036486 cites W2105936280 @default.
• W2022036486 cites W2117715744 @default.
• W2022036486 cites W2125204155 @default.
• W2022036486 cites W2129025256 @default.
• W2022036486 cites W2132128152 @default.
• W2022036486 cites W2138827805 @default.
• W2022036486 cites W2150438000 @default.
• W2022036486 cites W2153564398 @default.
• W2022036486 cites W2154050772 @default.
• W2022036486 cites W2159969745 @default.
• W2022036486 cites W2160950000 @default.
• W2022036486 cites W2169226612 @default.
• W2022036486 cites W2336672206 @default.
• W2022036486 doi "https://doi.org/10.1161/circulationaha.110.014860" @default.
• W2022036486 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4220292" @default.
• W2022036486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21768545" @default.
• W2022036486 hasPublicationYear "2011" @default.
• W2022036486 type Work @default.
• W2022036486 sameAs 2022036486 @default.
• W2022036486 citedByCount "69" @default.
• W2022036486 countsByYear W20220364862012 @default.
• W2022036486 countsByYear W20220364862013 @default.
• W2022036486 countsByYear W20220364862014 @default.
• W2022036486 countsByYear W20220364862015 @default.
• W2022036486 countsByYear W20220364862016 @default.
• W2022036486 countsByYear W20220364862017 @default.
• W2022036486 countsByYear W20220364862018 @default.
• W2022036486 countsByYear W20220364862019 @default.
• W2022036486 countsByYear W20220364862020 @default.
• W2022036486 countsByYear W20220364862021 @default.
• W2022036486 countsByYear W20220364862022 @default.
• W2022036486 countsByYear W20220364862023 @default.
• W2022036486 crossrefType "journal-article" @default.
• W2022036486 hasAuthorship W2022036486A5000351033 @default.
• W2022036486 hasAuthorship W2022036486A5008504819 @default.
• W2022036486 hasAuthorship W2022036486A5035615314 @default.
• W2022036486 hasAuthorship W2022036486A5038199459 @default.
• W2022036486 hasAuthorship W2022036486A5059098934 @default.
• W2022036486 hasAuthorship W2022036486A5070819007 @default.
• W2022036486 hasAuthorship W2022036486A5071915821 @default.
• W2022036486 hasAuthorship W2022036486A5073676650 @default.
• W2022036486 hasAuthorship W2022036486A5077862111 @default.
• W2022036486 hasAuthorship W2022036486A5089724515 @default.
• W2022036486 hasAuthorship W2022036486A5089890051 @default.
• W2022036486 hasBestOaLocation W20220364861 @default.
• W2022036486 hasConcept C126322002 @default.
• W2022036486 hasConcept C134018914 @default.
• W2022036486 hasConcept C2776825266 @default.
• W2022036486 hasConcept C2777180221 @default.
• W2022036486 hasConcept C2779036427 @default.
• W2022036486 hasConcept C2779306644 @default.
• W2022036486 hasConcept C2779679481 @default.
• W2022036486 hasConcept C2780675426 @default.
• W2022036486 hasConcept C555293320 @default.
• W2022036486 hasConcept C71924100 @default.
• W2022036486 hasConceptScore W2022036486C126322002 @default.
• W2022036486 hasConceptScore W2022036486C134018914 @default.
• W2022036486 hasConceptScore W2022036486C2776825266 @default.
• W2022036486 hasConceptScore W2022036486C2777180221 @default.
• W2022036486 hasConceptScore W2022036486C2779036427 @default.
• W2022036486 hasConceptScore W2022036486C2779306644 @default.
• W2022036486 hasConceptScore W2022036486C2779679481 @default.

• next